Pharmaxis Europe Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PHARMAXIS EUROPE, and what generic and branded alternatives to PHARMAXIS EUROPE drugs are available?
PHARMAXIS EUROPE has two approved drugs.
Drugs and US Patents for Pharmaxis Europe
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmaxis Europe | ARIDOL KIT | mannitol | POWDER;INHALATION | 022368-001 | Oct 5, 2010 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Pharmaxis Europe | BRONCHITOL | mannitol | POWDER;INHALATION | 202049-001 | Oct 30, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Pharmaxis Europe
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pharmaxis Europe | ARIDOL KIT | mannitol | POWDER;INHALATION | 022368-001 | Oct 5, 2010 | 5,817,028 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.